Real-world evidence in hepatocellular carcinoma
- PMID: 34155788
- DOI: 10.1111/liv.14864
Real-world evidence in hepatocellular carcinoma
Abstract
Real-world evidence includes all health-related information, such as electronic health records, insurance claims, pharmacy records and wearables that are obtained outside of clinical trials. These data can provide critical insights into the natural history of disease and evaluate the safety and effectiveness of treatment regimens used in clinical practice. Real-world data have been applied to varying degrees by global regulatory agencies to inform and expedite many phases of drug development and help refine the use of therapeutic regimens after marketing, especially in populations that are under-represented in registration trials. For the management of hepatocellular carcinoma, early detection provides the best chance for curative therapies, whose success has been evaluated in numerous cohorts. The availability of novel systemic therapies, including kinase inhibitors and immunotherapies, has provided new treatment options and improved survival in patients with advanced stage hepatocellular carcinoma. Real-world longitudinal observational studies can help understand the long-term safety and effectiveness of these agents.
Keywords: hepatocellular carcinoma; real-world data; real-world evidence.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Galson SK, Simon G. Real-world evidence to guide the approval and use of new treatments. NAM Perspectives. 2016;6(10).
-
- Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence - what is it and what can it tell us? N Engl J Med. 2016;375:2293-2297.
-
- Califf RM, Robb MA, Bindman AB, et al. Transforming evidence generation to support health and health care decisions. N Engl J Med. 2016;375:2395-2400.
-
- Sherman RE, Davies KM, Robb MA, Hunter NL, Califf RM. Accelerating development of scientific evidence for medical products within the existing US regulatory framework. Nat Rev Drug Discov. 2017;16:297-298.
-
- Mishra P, Florian J, Peter J, et al. Public-private partnership: targeting real-world data for hepatitis C direct-acting antivirals. Gastroenterology. 2017;153:626-631.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical